Global Information
회사소개 | 문의 | 비교리스트

카스포펀진 시장(2020-2026년)

Caspofungin Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949648
페이지 정보 영문
가격
US $ 3,600 ₩ 4,254,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,672,000 Printable PDF (Enterprise License)


카스포펀진 시장(2020-2026년) Caspofungin Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

세계 카스포펀진 시장은 예측기간 중 연평균 복합 성장률(CAGR) 약 5%로 성장할 것으로 예상됩니다. 카스포펀진은 다양한 세균 감염증 치료에 사용됩니다. 또한 위, 폐, 식도 등 체내 부위 감염증 치료에도 사용됩니다. 카스포펀진은 에키노칸딘(echinocandins)이라고 불리는 항진균제 클래스에 속합니다. 카스포펀진은 부작용 발생률이 낮기 때문에 이 점이 카스포펀진 시장 성장에 크게 기여할 것으로 예상됩니다.

지역적으로 세계 카스포펀진 시장 조사에서는 북미(미국, 캐나다), 유럽(영국, 독일, 이탈리아, 스페인, 프랑스, 기타), 아시아태평양(중국, 일본, 인도, 기타),기타 지역의 4개 지역별로 분석됩니다. 아시아태평양은 예측기간 중 높은 성장률을 나타낼 것으로 예측됩니다. 북미는 시장의 큰 점유율에 기여할 것으로 예상됩니다. 북미의성장은 현재 이용 가능한 것에 대해 내성을 나타낸 환자에 대한 항진균제 대체물을 탐구하는 연구개발이 활성화되어 있기 때문입니다.

세계의 카스포펀진(Caspofungin) 시장에 대해 조사했으며, 시장 개요, 감염 유형별·제형별·지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 구도

  • 주요 전략 분석
  • 주요 기업 분석
    • AthenexInc.
    • Merck&Co. Inc.
    • Fresenius SE&Co. KGaA
    • New Xellia Group A/S

제4장 시장 결정요인

  • 동기
  • 성장 억제요인
  • 시장 기회

제5장 시장 세분화

  • 감염 유형별 시장
    • 칸디다증
    • 아구창(Thrush)
  • 제형별 시장
    • 분말
    • 연고
    • 정제

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • Altan Pharma Ltd.
  • Alvogen
  • Centrient Pharmaceuticals
  • Cipla Ltd.
  • Fresenius SE & Co. KGaA
  • LivealthBioPharma Pvt. Ltd.
  • MDA Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • New Xellia Group A/S
  • ParchemFine &Specialty Chemicals
  • Pfizer Inc.
  • Rewine Pharmaceutical
  • Sanofi SA
  • Stanex Drugs and Chemicals Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • SVAK Life Sciences
  • Teva Pharmaceutical Industries Ltd.
LSH 20.08.05

LIST OF TABLES

  • 1. GLOBAL CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY INFECTION TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBALCANDIDIASISMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL THRUSHMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2019-2026 ($ MILLION)
  • 5. GLOBALCASPOFUNGINPOWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL CASPOFUNGINOINTMENTSMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL CASPOFUNGINDRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 9. NORTH AMERICAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2019-2026 ($ MILLION)
  • 11. NORTH AMERICAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY INFECTION TYPE, 2019-2026 ($ MILLION)
  • 12. EUROPEAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 13. EUROPEAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2019-2026 ($ MILLION)
  • 14. EUROPEAN CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY INFECTION TYPE, 2019-2026 ($ MILLION)
  • 15. ASIA-PACIFIC CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 16. ASIA-PACIFIC CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2019-2026 ($ MILLION)
  • 17. ASIA-PACIFIC CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY INFECTION TYPE, 2019-2026 ($ MILLION)
  • 18. REST OF THE WORLD CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2019-2026 ($ MILLION)
  • 19. REST OF THE WORLD CASPOFUNGIN MARKET RESEARCH AND ANALYSIS BY INFECTION TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CASPOFUNGIN MARKET SHARE BY INFECTION TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL CASPOFUNGIN MARKET SHARE BY DOSAGE FORMS, 2019 VS 2026 (%)
  • 3. GLOBAL CASPOFUNGIN MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD CASPOFUNGIN MARKET SIZE, 2019-2026 ($ MILLION)

Global Caspofungin Market Size, Share & Trends Analysis Report ByInfection Type (Candidiasis and Thrush), By Dosage Forms (Powders, Ointments, and Drugs), and Forecast 2020-2026

The global caspofunginmarket is anticipated to grow at a CAGR of around 5% during the forecast period.Caspofunginisused in the treatment ofvarious bacterial infections. Additionally, caspofungin is also used in the treatment of infections in the internal body areas including the stomach, lungs, esophagus.Caspofungin belongs to the class of antifungals that is termed as the echinocandins. Caspofungin appears to have a lower incidence of adverse effects which is anticipated to contributesignificantly to the growth of the caspofunginmarket.

The caspofungin market is segmented on the basis of the infection type and dosage form. Based on the infection type, the market is sub-segmented into candidiasis and thrush. The candidiasis segment is estimated to contributea prominent share over the forecast period. The segmental growth of the market is attributed to the increasing prevalence of esophageal candidiasis among men and vaginal yeast infections among women. Further based on the dosage forms, the market is sub-segmented into powders, ointments, and drugs.

Geographically, the study of the global caspofunginmarket report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global caspofunginmarket during the forecast period.North America is expected to contributea prominent sharein themarket. The growth in the region is due to the increased R&D activities to find the alternative of anti-fungal drugs for the patient that has developed resistance to the currently available one.

Some of thekey players of the global caspofunginmarket includeAthenex Inc., Fresenius SE & Co. KGaA,Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., New Xellia Group A/S,Centrient Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and others.

Research Methodology

The market study of the global caspofunginmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for thecaspofungin manufacturers,pharmaceutical industry, drug manufacturing companies, active pharmaceutical ingredient manufacturers, hospitals& clinics,government organizations, regulatoy bodies, and other market participantsfor overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. GlobalCaspofunginMarket Research and Analysis by Infection Type

2. Global Caspofungin Market Research and Analysis by Dosage Forms

The Report Covers:

  • Comprehensive research methodology of the global caspofunginmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global caspofunginmarket.
  • Insights about market determinants which are stimulating the global caspofunginmarket.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. AthenexInc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. Merck & Co. Inc.
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Fresenius SE & Co. KGaA
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. New Xellia Group A/S
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Caspofungin Market by Infection Type
    • 5.1.1. Candidiasis
    • 5.1.2. Thrush
  • 5.2. Global CaspofunginMarket by Dosage Forms
    • 5.2.1. Powders
    • 5.2.2. Ointments
    • 5.2.3. Drugs

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Altan Pharma Ltd.
  • 7.2. Alvogen
  • 7.3. Centrient Pharmaceuticals
  • 7.4. Cipla Ltd.
  • 7.5. Fresenius SE & Co. KGaA
  • 7.6. LivealthBioPharma Pvt. Ltd.
  • 7.7. MDA Inc.
  • 7.8. Merck & Co. Inc.
  • 7.9. Mylan NV
  • 7.10. New Xellia Group A/S
  • 7.11. ParchemFine &Specialty Chemicals
  • 7.12. Pfizer Inc.
  • 7.13. Rewine Pharmaceutical
  • 7.14. Sanofi SA
  • 7.15. Stanex Drugs and Chemicals Pvt. Ltd.
  • 7.16. Sun Pharmaceutical Industries Ltd.
  • 7.17. SVAK Life Sciences
  • 7.18. Teva Pharmaceutical Industries Ltd.
Back to Top
전화 문의
F A Q